The bill amends Chapter 5-37.8 of the General Laws, known as the "Protections for Healthcare Providers Act," by adding a new section that establishes prescriptive protections for providers involved in legally protected healthcare activities. Specifically, it mandates that the prescription label for medication abortion prescription drugs must include the name of the dispensing healthcare practice instead of the name of the individual dispenser. This change aims to enhance the confidentiality and protection of healthcare providers involved in administering medication abortions.

Additionally, the bill defines "medication abortion prescription drugs" as substances used in the course of medical treatment intended to induce the termination of a pregnancy, including, but not limited to, mifepristone and misoprostol. The act is set to take effect immediately upon passage.